Votes: NJ A2830 | 2020-2021 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Introduced - Dead) 2020-02-20 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A2830 Detail]

Text: Latest bill text (Introduced) [HTML]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
No roll call record information currently on file.
States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on NJ A2830

feedback